What to Do With Four Winners and One Loser
Four of our stocks have been soaring due to good reports on clinical studies, and one dropped about 30% yesterday when the CEO of the company gave a less-than-euphoric presentation to investors. This...
View ArticleBoundless Prosperity
An insanely optimistic episode of The 5: One day that symbolizes the biggest biotech bull market ever, plus The New York Times discovers a re-made America, nearly three years after we did
View ArticleRoaring Wealth Creation from These Two Sectors
An insanely optimistic episode of The 5: One day that symbolizes the biggest biotech bull market ever, plus The New York Times discovers a re-made America, nearly three years after we did
View ArticleBeating the Market, Slowly
This is your one-stop-shop issue to trade the market with zero effort. We have 7 funds for you today. Ones we actually LIKE!
View ArticleNew Recommendation: A Payout From a Regrettable Pending New War
Last night’s presidential address paves the way for today’s instant payout – earning a nice payout for just 37 days of work.
View ArticleReader Mail and Portfolio Updates
Over the past month, one of our holdings has been selling off. As I write, it's down 22%. From a fundamental standpoint, the business is in good shape. Seventy percent of the market capitalization is...
View ArticleMore On Yesterday’s Trade – Plus, Portfolio Update
Looks like everyone that wanted to get in on yesterday’s trade should have been filled. Let’s take a look at the most recent addition to our portfolio along with a full rundown of our current portfolio…
View ArticleSTORM Cast: Green Means Buy, Red Means Sell
In today's STORM Cast, I'll show you exactly how we used that stoplight model to wring money out of the S&P 500 index for the second time this year. I'll also show you two new names I'm adding to...
View ArticleSTORM Cast: Green Means Buy, Red Means Sell
In today's STORM Cast, I'll show you exactly how we used that stoplight model to wring money out of the S&P 500 index for the second time this year. I'll also show you two new names I'm adding to...
View ArticleFollow the CEO
Give it a few years and spinoff investors will have a triple. The CEO of our newest pick must agree with me… he jumped ship to head the spinoff! Plus, invest without a home country bias.
View ArticleHit a Double With the “X2 Factor”
Recently, a quiet deal was struck in halls of the Pentagon. This deal, as you’ll soon see, could take the fortune of one American legacy company higher. Much higher. I call it the “X2 Factor,” and...
View ArticleThe Age of Venality: How to Protect Yourself
A short seller (and fraud detector) speaks out at the VIC. Three tips to keep tabs on management.
View ArticleFive World-Changing Companies to Deliver You Ultra-Wealth
Thirty years ago, I was introduced to a wonderful financial guru. He seemed like an ordinary enough stockbroker at the time, but I came to discover that he had been a star at a major brokerage house in...
View ArticleArmies and Debts and Taxes
Why The 5 isn’t joining in a certain “patriotic” celebration. Plus: Following Mr. Market’s cue for 46% gains.
View Article$5.5 Million for What?!
Why The 5 isn’t joining in a certain “patriotic” celebration. Plus: Following Mr. Market’s cue for 46% gains.
View ArticleEnergy Advisor
In this month’s Energy Advisor, Byron brings you an insider look at a service company that skyrocketing thanks to a new development in tight oil technology. You’ve probably never heard of them before,...
View ArticleWar, Peace — Who Pays, Who Cashes In?
With the United States barreling into another war, Neil looks at stocks that could benefit, and also explains how the vote for Scottish independence could affect our London-based stocks.
View ArticleA Good Chance for Worry-Free Payouts
With one position set to expire today and several more expiring next week, we’re looking very good to keep all of our instant payouts.
View ArticleThe Ebola Threat Continues to Rise, Plus a Sell
With cases mounting, the Ebola virus outbreak continues to raise concerns. We don't know what's going to happen, and some of the things that could happen are worrisome. The great bulk of the cases are...
View ArticleMarket Wrap-Up: You Dodged a Bullet
In a moment, I'm going to show you a technical update on where the broad market is headed for the rest of September. But before I do, I have a quick note for some of the new readers here today.
View Article